Published in Blood Weekly, July 19th, 2007
"Since the January 25, 2007 Effective Registration statement the holders of this convertible debt have been selling our common stock," said Matthew Schissler, CEO. "We are well aware that this has been a significant drag on the market and we are grateful for our many investors who have patiently waited through this difficult period. We have confirmed that the holders...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.